Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/AMGN
icon
Up to 4x
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Amgen, Inc. (AMGN) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Amgen (AMGN) declined 10.08% to $393.17 following negative sentiment from a competitor's clinical trial setback, despite strong fundamental performance. The stock maintains bullish technical indicators with support at $428 and resistance at $442. Recent earnings beats and robust profitability metrics, including 69.52% gross margins and 91.47% ROE, underscore operational strength. Revenue growth accelerated to $36.75B in 2025, with net income reaching $7.71B.
The outlook remains positive with analyst consensus at Buy (57.5%) and a $398.52 price target, though near-term volatility from pipeline uncertainties poses risks. Long-term growth drivers include MariTide's obesity market potential and Repatha's cardiovascular benefits, balanced by competitive pressures in the pharmaceutical sector.
Read full analysis

Key Stats

  • Market Cap
    $212.56B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $444.12
  • 52W Low
    $271.18
  • Typical Hold Time
    -
  • Enterprise Value
    $255.88B
  • Div Yield
    2.56%
  • Trading Activity
    -
$392.96
52W Low: $271.18
25 Sep 2025
52W High: $444.12
03 Sep 2026

Track Amgen, Inc. (AMGN) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Amgen, Inc. has traded between a low of $271.18 and a high of $444.12, highlighting its annual price range. Buy and sell Amgen, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Amgen, Inc.

Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).

Most Recent News

Content is generated by Aura AI

Caterpillar leads AI-driven industrial shift as 10-year Treasury yields near 5%, signaling market rotation.

Piper Sandler's Craig Johnson highlights a market rotation from traditional AI leaders to industrials like Caterpillar, driven by rising 10-year Treasury yields nearing 5%. This shift reflects a broader move where industries with heavy labor and low ...

Market News
4 hours ago
24/7 Wall Street
Bullish
news icon
Caterpillar leads AI-driven industrial shift as 10-year Treasury yields near 5%, signaling market rotation.

Memory chip stocks rise as Goldman Sachs says sector's worst downturn may be over.

Memory chip stocks including SK Hynix, Micron, and SanDisk rose after Goldman Sachs turned bullish, suggesting the worst of the sector's downturn might be behind. The rally comes amid improved technical signals, lighter hedge fund positioning, and ex...

Market News
4 hours ago
24/7 Wall Street
Bullish
news icon
Memory chip stocks rise as Goldman Sachs says sector's worst downturn may be over.

West Virginia American Water invests $275K to upgrade water pipes on Thompson Avenue in Bluefield.

West Virginia American Water is investing $275,000 to replace 600 feet of aging water pipes on Thompson Avenue in Bluefield, aiming to improve water service reliability and safety. The project will run through October 2026, with some temporary servic...

Market News
4 hours ago
PRNewsWire
Bullish
news icon
West Virginia American Water invests $275K to upgrade water pipes on Thompson Avenue in Bluefield.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $212.56B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $444.12
  • 52W Low
    $271.18
  • Typical Hold Time
    -
  • Enterprise Value
    $255.88B
  • Div Yield
    2.56%
  • Trading Activity
    -
$392.96
52W Low: $271.18
25 Sep 2025
52W High: $444.12
03 Sep 2026

Track Amgen, Inc. (AMGN) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Amgen, Inc. has traded between a low of $271.18 and a high of $444.12, highlighting its annual price range. Buy and sell Amgen, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!